Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report

Astellas Pharma Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa (EMEA) and Oceania. It is headquartered in Tokyo, Japan and employed 17,217 people as of March 31, 2016.

Scope

– Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments

– Intelligence on Astellas Pharma Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Astellas Pharma Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Astellas Pharma Inc.: Company Overview

Astellas Pharma Inc.: Overview and Key Facts

Astellas Pharma Inc.: Overview

Astellas Pharma Inc.: Key Facts

Astellas Pharma Inc.: Key Employees

Astellas Pharma Inc.: Key Employee Biographies

Astellas Pharma Inc.: Major Products and Services

Astellas Pharma Inc.: Company History

Astellas Pharma Inc.: Management Statement

Astellas Pharma Inc.: Locations and Subsidiaries

Astellas Pharma Inc.: Key Competitors

Astellas Pharma Inc.: Company Analysis

Astellas Pharma Inc.: Business Description

Astellas Pharma Inc.: SWOT Analysis

Astellas Pharma Inc.: SWOT Overview

Astellas Pharma Inc.: Strengths

Astellas Pharma Inc.: Weaknesses

Astellas Pharma Inc.: Opportunities

Astellas Pharma Inc.: Threats

Astellas Pharma Inc.: Corporate Financial Deals Activity

Astellas Pharma Inc.: Financial Deals Overview

Astellas Pharma Inc.: Targets and Partners

Astellas Pharma Inc.: Top Deals 2013 - 2017YTD*

Astellas Pharma Inc.: Advisors

Astellas Pharma Inc.: Top Legal Advisors

Astellas Pharma Inc.: Mergers and Acquisitions

Astellas Pharma Inc.: Corporate Venturing

Astellas Pharma Inc.: Partnership

Astellas Pharma Inc.: Divestments

Astellas Pharma Inc.: Recent Developments

Astellas Pharma Inc.: News and Events Summary

Astellas Pharma Inc.: Business Expansion

Astellas Pharma Inc.: Corporate Social Responsibility

Astellas Pharma Inc.: Financial Deals

Astellas Pharma Inc.: Market Developments

Astellas Pharma Inc.: Regulatory and Legal Events

Astellas Pharma Inc.: Research & Development

Astellas Pharma Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: Astellas Pharma Inc.: Key Facts

Table 2: Astellas Pharma Inc.: Key Employees

Table 3: Astellas Pharma Inc.: Locations and Subsidiaries

Table 4: Astellas Pharma Inc.: Key Competitors

Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Table 7: Astellas Pharma Inc.: M&A Average Deal Size – Value (US$m)

Table 8: Astellas Pharma Inc.: Targets and Partners

Table 9: Astellas Pharma Inc.: Top Deals 2013 – 2017YTD*

Table 10: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)

Table 11: Astellas Pharma Inc.: M&A Volume and Value Trend (2013 – YTD*2017)

Table 12: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Table 13: Astellas Pharma Inc.: Corporate Venturing by Geography (2013 – YTD*2017)

Table 14: Astellas Pharma Inc.: Partnership Volume and Value Trend (2013 – YTD*2017)

Table 15: Astellas Pharma Inc.: Partnership Trend by Deal Type (2013 – YTD*2017)

Table 16: Astellas Pharma Inc.: Divestments Volume and Value Trend (2013 – YTD*2017)

Table 17: Astellas Pharma Inc.: Divestments by Geography (2013 – YTD*2017)

Table 18: Astellas Pharma Inc.: News and Events Summary

Table 19: Astellas Pharma Inc.: Business Expansion

Table 20: Astellas Pharma Inc.: Corporate Social Responsibility

Table 21: Astellas Pharma Inc.: Financial Deals

Table 22: Astellas Pharma Inc.: Market Developments

Table 23: Astellas Pharma Inc.: Regulatory and Legal Events

Table 24: Astellas Pharma Inc.: Research & Development

Table 25: Astellas Pharma Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Astellas Pharma Inc.: Deal Activity by Deal Type – Volume (2013 – YTD*2017)

Figure 3: Astellas Pharma Inc.: M&A Average Deal Size – Value (US$m)

Figure 4: Astellas Pharma Inc.: M&A Volume and Value Trend (2013 – YTD*2017)

Figure 5: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2013 – YTD*2017)

Figure 6: Astellas Pharma Inc.: Corporate Venturing by Geography (2013 – YTD*2017)

Figure 7: Astellas Pharma Inc.: Partnership Volume and Value Trend (2013 – YTD*2017)

Figure 8: Astellas Pharma Inc.: Partnership Trend by Deal Type (2013 – YTD*2017)

Figure 9: Astellas Pharma Inc.: Divestments Volume and Value Trend (2013 – YTD*2017)

Figure 10: Astellas Pharma Inc.: Divestments by Geography (2013 – YTD*2017)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports